Abstract
Kidney disease continues to be a problem with antiretorviral therapy in patients with HIV infection, its incidence varies from 2.7 to 6.9 per 100 person-years. There is growing evidence that antiretorviral therapy can cause a wide variety of nephrotoxic effects and severe acute kidney injury, however, reported cases of crystalline nephropathy from the use of Darunavir (DRV) are rare.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
